MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-16948

  1. 16,584 Posts.
    lightbulb Created with Sketch. 8092
    "Delivery of the cells has been key to the CHF, yet when I advocated this was the case @madamswer and other ridiculed."

    Nargh.
    I am unqualified to post on such weighty matters, so I wouldn't do so.

    What I do admitting to posting, however, on numerous occasions over a period of a number of years, is the prudent management of investment risk by investing in only companies that have reached "self-sustaining commercialisation". (Not sure if you recall seeing the phrase).

    In fact, when I tonight saw I had been tagged by someone on the MSB thread, I suspected that it might be someone alerting me to the fact that the company had finally reached that elusive point of self sustaining commercialisation.

    But no, 'twas not to be.

    Maybe next year?

    Yes, next year might be the year that the Meso-Rocket finally blasts off to that Great Money Planet in the Cosmos.

    .
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.